A multiarm phase 1b study of personalized oral maintenance therapy with decitabine/cedazuridine (ASTX727) plus physician's choice of venetoclax, gilteritinib, enasidenib, or ivosidenib in Acute Myeloid Leukemia
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Alexandre Bazinet, Farhad Ravandi, Naval Daver, Nicholas Short, Maro Ohanian, Musa Yilmaz, Koji Sasaki, Elias Jabbour, Kelly Chien, Courtney DiNardo, Fadi Haddad, Danielle Hammond, Jo Ishizawa, Nitin Jain, Abhishek Maiti, Lucia Masarova, William Wierda, Guillermo Garcia-Manero, Hagop Kantarjian, Tapan Kadia
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417020048
Cites:
Cited by:
Related to: